Taiwan FDA registration f0a848e2a3b6a634b4490317717dd03a
Apibeta barbital test group
TW: 亞培苯基巴比妥檢驗試劑組
Taiwan·Risk Class 2·B.R.A.H.M.S GmbH;; MICROGENICS CORPORATION·Registered Jan 06, 2020 – Jan 06, 2030ActiveRegistration details
- Analysis ID
- f0a848e2a3b6a634b4490317717dd03a
- Customs Code
- DHA05603312302
Company information
- Manufacturer
- B.R.A.H.M.S GmbH;; MICROGENICS CORPORATION
- Manufacturer Country
- United States;;Germany
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- This product is used for the in vitro quantitative detection of phenylbarbital in human serum or plasma on the Alinity c analyzer.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3660 苯基巴比妥試驗系統
- Import Information
- Input;; Contract manufacturing
Dates and status
- Registration Date
- Jan 06, 2020
- Expiry Date
- Jan 06, 2030
About this record
Access comprehensive regulatory information for Apibeta barbital test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f0a848e2a3b6a634b4490317717dd03a and manufactured by B.R.A.H.M.S GmbH;; MICROGENICS CORPORATION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices